PURPOSE: We characterized the performance of a novel hyperpolarized perfusion marker, α-trideuteromethyl[15N]glutamine, for direct comparison with a 13C-based hyperpolarized perfusion marker, [13C, 15N2]urea. METHODS: A hardware platform and pulse sequence for in vivo 15N experiments were established. Hyperpolarized solutions of α-trideuteromethyl[15N]glutamine and [13C, 15N2]urea were injected into healthy male Lewis rats. Kidney slice images were acquired using a single-shot spiral readout. Both compounds were compared to determine in vivo signal lifetime and tracer distribution. Mass spectrometry was performed to evaluate excretion of the compound. RESULTS: Compared with 13C-labeled urea, a significantly increased signal lifetime was observed. While the urea signal was gone after 90 s, decay of the glutamine compound was sufficiently slow to obtain a quantifiable signal, even after 5 min. The glutamine derivative showed strong localization in the kidneys with little background signal. Effective T1 of α-trideuteromethyl[15N]glutamine was approximately eight-fold higher than that of urea. Mass spectrometry results confirmed rapid excretion within the time scale of the measurement. CONCLUSION: Hyperpolarized α-trideuteromethyl[15N]glutamine is a highly promising candidate for renal studies because of its long signal lifetime, strong localization and rapid excretion. Magn Reson Med 76:1900-1904, 2016.
PURPOSE: We characterized the performance of a novel hyperpolarized perfusion marker, α-trideuteromethyl[15N]glutamine, for direct comparison with a 13C-based hyperpolarized perfusion marker, [13C, 15N2]urea. METHODS: A hardware platform and pulse sequence for in vivo 15N experiments were established. Hyperpolarized solutions of α-trideuteromethyl[15N]glutamine and [13C, 15N2]urea were injected into healthy male Lewis rats. Kidney slice images were acquired using a single-shot spiral readout. Both compounds were compared to determine in vivo signal lifetime and tracer distribution. Mass spectrometry was performed to evaluate excretion of the compound. RESULTS: Compared with 13C-labeled urea, a significantly increased signal lifetime was observed. While the urea signal was gone after 90 s, decay of the glutamine compound was sufficiently slow to obtain a quantifiable signal, even after 5 min. The glutamine derivative showed strong localization in the kidneys with little background signal. Effective T1 of α-trideuteromethyl[15N]glutamine was approximately eight-fold higher than that of urea. Mass spectrometry results confirmed rapid excretion within the time scale of the measurement. CONCLUSION: Hyperpolarized α-trideuteromethyl[15N]glutamine is a highly promising candidate for renal studies because of its long signal lifetime, strong localization and rapid excretion. Magn Reson Med 76:1900-1904, 2016.
Authors: Nikita V Chukanov; Bryce E Kidd; Larisa M Kovtunova; Valerii I Bukhtiyarov; Roman V Shchepin; Eduard Y Chekmenev; Boyd M Goodson; Kirill V Kovtunov; Igor V Koptyug Journal: J Labelled Comp Radiopharm Date: 2019-01-07 Impact factor: 1.921
Authors: Kirill V Kovtunov; Larisa M Kovtunova; Max E Gemeinhardt; Andrey V Bukhtiyarov; Jonathan Gesiorski; Valerii I Bukhtiyarov; Eduard Y Chekmenev; Igor V Koptyug; Boyd M Goodson Journal: Angew Chem Int Ed Engl Date: 2017-07-28 Impact factor: 15.336
Authors: Maximilian Fuetterer; Julia Busch; Sophie M Peereboom; Constantin von Deuster; Lukas Wissmann; Miriam Lipiski; Thea Fleischmann; Nikola Cesarovic; Christian T Stoeck; Sebastian Kozerke Journal: J Cardiovasc Magn Reson Date: 2017-06-21 Impact factor: 5.364
Authors: Maximilian Fuetterer; Julia Busch; Julia Traechtler; Patrick Wespi; Sophie M Peereboom; Mareike Sauer; Miriam Lipiski; Thea Fleischmann; Nikola Cesarovic; Christian T Stoeck; Sebastian Kozerke Journal: J Cardiovasc Magn Reson Date: 2018-11-12 Impact factor: 5.364
Authors: Geoffrey J Topping; Christian Hundshammer; Luca Nagel; Martin Grashei; Maximilian Aigner; Jason G Skinner; Rolf F Schulte; Franz Schilling Journal: MAGMA Date: 2019-12-06 Impact factor: 2.310
Authors: Cornelius von Morze; John A Engelbach; Galen D Reed; Albert P Chen; James D Quirk; Tyler Blazey; Rohit Mahar; Craig R Malloy; Joel R Garbow; Matthew E Merritt Journal: Magn Reson Med Date: 2020-11-12 Impact factor: 4.668